Eric Devroe
Operationeel Directeur bij ACRIVON THERAPEUTICS, INC.
Vermogen: 505 744 $ op 30-04-2024
Profiel
Eric J.
Devroe was the founder of Opsonix, Inc. (founded in 2015), where he held the position of Chief Executive Officer & Director from 2015 to 2018.
Dr. Devroe is also the founder of Xione Therapeutics, Inc. Dr. Devroe's current job is Chief Operating Officer at Acrivon Therapeutics, Inc. where he started in 2022.
Dr. Devroe's former jobs include Scientist at Asuragen, Inc., Principal at Codon Devices, Inc., and VP-Business & Strategy Development at Metamark Genetics, Inc. Dr. Devroe received a doctorate degree from Harvard University and an undergraduate degree from the University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2024 | 59 710 ( 0.19% ) | 505 744 $ | 30-04-2024 |
Actieve functies van Eric Devroe
| Bedrijven | Functie | Begin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Operationeel Directeur | 01-08-2022 |
Eerdere bekende functies van Eric Devroe
| Bedrijven | Functie | Einde |
|---|---|---|
Opsonix, Inc.
 Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Oprichter | 01-01-2018 |
Xione Therapeutics, Inc.
 Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Algemeen Directeur | - |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Operationeel Directeur | 23-03-2011 |
Opleiding van Eric Devroe
| Harvard University | Doctorate Degree |
| University of Texas at Austin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Opsonix, Inc.
Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Xione Therapeutics, Inc.
Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Health Technology |
